<div id="readability-page-1"><div>Cathie Wood is sticking to her playbook. In her latest weekly update, ARK Invest leaned further into long-term bets on AI infrastructure, gene editing and autonomous technology, while continuing to cut back exposure to Tesla and other more mature names.On the buying side, ARK added to positions in Advanced Micro Devices, Broadcom and Taiwan Semiconductor Manufacturing. The moves underline Wood's conviction that demand for AI computing and chip infrastructure still has plenty of room to grow, even after a strong run for the sector.ARK also stayed active in life sciences, but with a clear tilt. The firm added shares of Intellia Therapeutics, 10x Genomics, GeneDx and Personalis, while trimming legacy sequencing and diagnostics names. The message is a familiar one from Wood: shift capital toward what ARK sees as next-generation, editing-first platforms.Autonomous driving and robotics were another focus. ARK added exposure to robotaxis, autonomous trucking and vehicle intelligence across several of its ETFs, reinforcing its long-term automation thesis.On the flip side, ARK sold more than 86K shares of Tesla worth over $37 million and trimmed holdings in Illumina, Intuit and other software and life sciences names. ARK is clearly rotating away from established leaders and doubling down on early-stage technologies it believes can define the next decade. Investors will be watching whether these high-conviction bets can pay off in a volatile market.</div></div>

Cathie Wood's ARK Invest is increasing investments in AI infrastructure and gene editing while reducing exposure to Tesla and other mature companies. Recent purchases include Advanced Micro Devices, Broadcom, and Taiwan Semiconductor Manufacturing, reflecting confidence in AI chip demand. ARK also invested in life sciences firms like Intellia Therapeutics and 10x Genomics, while selling over 86K shares of Tesla. The strategy emphasizes a shift towards next-generation technologies and automation, with a focus on robotaxis and autonomous trucking.

- ARK Invest, led by Cathie Wood, is increasing investments in AI infrastructure, gene editing, and autonomous technology while reducing exposure to established companies like Tesla.  
- The firm has added positions in Advanced Micro Devices, Broadcom, and Taiwan Semiconductor Manufacturing, signaling confidence in the growth of AI computing demand.  
- ARK is shifting capital towards next-generation platforms and autonomous driving, indicating a strategy focused on early-stage technologies amid a changing market landscape.

GuruFocus

VanEck Semiconductor ETF

SPDR S&P Semicon

GraniteShares 2x Long TSM Daily ETF

GraniteShares 2x Long AMD Daily ETF

Invesco Semiconductors ETF

CRISPR Therap

Taiwan Semiconductor

Direxion Semicon Bull 3X

10X Genomics

Ark Genomic Revolution ETF

Intellia Therap

Direxion Daily AMD Bull 2X Shares

Franklin Genomic Adv ETF

Wisdomtree BioRevolution Fund ETF

Direxion Daily TSM Bull 2X Shares

Defiance Daily Target 2X Long AVGO ETF

iShares Semiconductor ETF

Invesco AI and Next Gen Software ETF

Roundhill AVGO WeeklyPay ETF

GraniteShares 2x Long AVGO Daily ETF

SPDR S&P Biotech

Leverage Shares 2X Long AVGO Daily ETF

Direxion Daily AVGO Bull 2X Shares

Broadcom

Cathie Wood Buys AI Chips, Sells Tesla